Key takeaways

  • Most STIs are asymptomatic, so testing is the only reliable way to know your status. No symptoms does not mean no infection.
  • Timing matters. Each infection has a window period; testing too soon after exposure can miss it. HIV needs a 4-6 week test plus a 12-week repeat.
  • Free, confidential (even anonymous) testing is available at NACO ICTC and Suvidha clinics. Private labs offer comprehensive panels from roughly Rs 2,500-7,000.
  • A comprehensive panel usually covers HIV, syphilis, chlamydia and gonorrhoea, and hepatitis B and C; add HSV, trichomoniasis, or throat and rectal swabs based on your exposures.
  • Most STIs are curable or manageable. A positive result is treatable, and early treatment prevents serious complications like infertility.
  • After high-risk HIV exposure, PEP started within 72 hours can prevent infection. Go to a NACO ART centre or major hospital urgently.

Who should get tested, and how often

  • Baseline screen: at least one comprehensive STI screen early in your sexual life, and again after any major change in partner status.
  • Annual screening: reasonable for anyone under 25, anyone with a new partner in the past year, or anyone whose partner may have other partners. The CDC specifically recommends yearly chlamydia and gonorrhoea screening for sexually active women under 25.
  • Every 3-6 months: for higher ongoing risk, men who have sex with men with multiple partners, transgender women, sex workers, people who inject drugs, and anyone on HIV PrEP (PrEP includes mandatory STI screening every 3 months).
  • Less often: couples in a mutually monogamous relationship where both partners have tested clear can test annually or as clinically indicated.
  • In pregnancy: India screens all pregnant women for HIV, syphilis, and hepatitis B under the PPTCT programme, usually at the first antenatal visit, with repeats later if risk continues.
  • After a specific event: condom breakage, sex with a partner of unknown or positive status, sexual assault, or a partner telling you they tested positive all trigger testing on a set timeline.
  • Any symptoms: genital discharge, painful urination, sores or ulcers, abnormal bleeding, or pelvic pain mean you should test without waiting for a routine slot.

Window periods: when each test becomes reliable

  • HIV: a 4th-generation antigen-antibody test detects most infections by 4-6 weeks and nearly all by 12 weeks. The standard for a high-risk exposure is to test at 4-6 weeks and again at 12 weeks. HIV RNA (NAAT) can detect from about 10-14 days but is expensive and reserved for special situations.
  • Chlamydia and gonorrhoea (NAAT): reliable from about 2 weeks after exposure; testing too early can miss it.
  • Syphilis: serology usually becomes reactive at 3-6 weeks, with most cases detectable by 12 weeks. A visible sore (chancre) can appear before the blood test turns positive.
  • Hepatitis B (HBsAg): detectable from about 4-10 weeks, occasionally up to 24 weeks.
  • Hepatitis C: antibody detectable from about 4-12 weeks, occasionally up to 24 weeks.
  • HSV-2 (type-specific IgG): detectable from about 12-16 weeks, though a swab or PCR of an active sore is more useful when there are symptoms.
  • Trichomoniasis: NAAT detects active infection with essentially no window period.
  • HPV: not tested as a routine exposure check; cervical HPV is part of cancer screening.

What a comprehensive STI panel includes

  • HIV: ask for the 4th-generation antigen-antibody test (often written "HIV 1&2 4th gen" or "HIV combo"). Rapid antibody-only tests have a longer window.
  • Syphilis: a screening test (VDRL or RPR) confirmed by a treponemal test (TPHA or FTA-ABS), or the reverse order. Positive results come with a titre (for example RPR reactive 1:8) that guides treatment.
  • Chlamydia and gonorrhoea: NAAT is the gold standard, from first-catch urine, a self-collected vaginal swab, or a clinician-collected swab. Ask for "CT/NG NAAT" and name the sites (genital, throat, rectal) you need.
  • Hepatitis B: HBsAg is the screening test; a full panel adds anti-HBs (immunity) and anti-HBc.
  • Hepatitis C: HCV antibody, confirmed by HCV RNA PCR if positive, to separate active from past infection.
  • Trichomoniasis: NAAT (gold standard) or wet-mount microscopy.
  • HSV: type-specific IgG for past infection, or swab/PCR of an active sore.
  • Cervical screening: a Pap smear with high-risk HPV co-testing, usually from age 25-30.
  • Site-specific testing: throat NAAT for anyone who performs oral sex and rectal NAAT for receptive anal sex; standard panels often skip these unless you ask.

Where to get tested in India

  • NACO ICTC and Suvidha clinics: over 30,000 sites offer free, confidential, often anonymous HIV testing with counselling; many also offer free syphilis, hepatitis B, and broader STI testing. The NACO helpline 1097 locates your nearest centre.
  • Government hospitals: STI, skin (dermatology), and gynaecology departments at teaching hospitals offer comprehensive testing for a small registration fee (around Rs 50-300), with tests free or marginal.
  • Private hospitals: faster and more comfortable, but a comprehensive panel runs roughly Rs 3,000-10,000.
  • Chain labs: Apollo Diagnostics, Metropolis, Thyrocare, SRL, and Dr Lal PathLabs offer panels around Rs 2,500-7,000, with home sample collection in major cities for a small extra fee.
  • Telehealth platforms: Practo, Tata 1mg, and Apollo 24x7 let a doctor order tests, often with home collection, useful for testing without an in-person visit.
  • Community and NGO services: the Humsafar Trust, Naz Foundation, Sahodari Foundation, Mitr Trust, and sex-worker collectives such as DMSC offer testing tuned to their communities, often free or low-cost.
  • Home self-collection: self-collected vaginal swabs for chlamydia, gonorrhoea, and trichomoniasis NAAT are clinically valid and endorsed by the CDC; home blood collection for HIV and syphilis is also available.

Cost, insurance, and access

  • HIV 4th-gen test: roughly Rs 600-1,500 privately; free at NACO ICTC.
  • Syphilis VDRL/RPR: roughly Rs 200-600.
  • Chlamydia/gonorrhoea NAAT (single site): roughly Rs 800-2,500.
  • Hepatitis B HBsAg: roughly Rs 200-500; full panel Rs 600-1,500.
  • Hepatitis C antibody: roughly Rs 400-1,000.
  • Pap smear with HPV co-testing: roughly Rs 1,500-4,000.
  • Comprehensive panel: roughly Rs 2,500-7,000 privately; free or subsidised at NACO/ICTC and government hospitals.

Reading your results

  • Negative (non-reactive / not detected): no infection detected at the time of testing. Remember the window period; a negative test taken too soon after exposure may need repeating.
  • Positive (reactive / detected): a positive screening test usually needs a confirmatory second test before a firm diagnosis. HIV and syphilis screens are confirmed with a second method; chlamydia/gonorrhoea NAAT is typically definitive.
  • Indeterminate / equivocal: neither clearly positive nor negative, often early infection or a technical issue. It usually resolves on a repeat test in 2-4 weeks. Do not panic.
  • False positive: more likely in low-prevalence settings, which is exactly why confirmatory testing exists. Syphilis VDRL/RPR can be falsely positive in pregnancy or with autoimmune conditions.
  • False negative: usually from testing inside the window period. Repeat at the right interval.
  • Quantitative results: syphilis titres and HIV viral load are numbers that track disease activity and treatment response.
  • Co-infections: a positive result for one STI is a reason to test for others that share transmission routes.

After a positive result: treatment and next steps

  • Chlamydia: doxycycline 100 mg twice daily for 7 days.
  • Gonorrhoea: ceftriaxone 500 mg as a single intramuscular dose, often with doxycycline added for possible chlamydia co-infection.
  • Syphilis: benzathine penicillin G 2.4 million units intramuscularly as a single dose for early syphilis.
  • Trichomoniasis: metronidazole, as a single 2 g dose or 500 mg twice daily for 7 days.
  • HIV: lifelong antiretroviral therapy, free at NACO ART centres; with treatment, undetectable equals untransmittable (U=U).
  • HSV: episodic antiviral therapy for outbreaks, or daily suppressive therapy if outbreaks are frequent.
  • Hepatitis C: direct-acting antivirals for 8-12 weeks cure over 95 percent of infections.

Special situations: PEP, PrEP, pregnancy, and assault

  • HIV PEP (after exposure): a 28-day course of antiretrovirals, started within 72 hours (ideally 24 hours) of a high-risk exposure, substantially cuts HIV transmission risk. It is free at NACO ART centres and available at major hospitals. Testing follows at baseline, 6 weeks, and 12 weeks.
  • HIV PrEP (before exposure): daily medication for HIV-negative people at ongoing high risk. NACO began rolling out PrEP in 2022. Learn more about PrEP for HIV prevention.
  • Pregnancy: HIV, syphilis, and hepatitis B screening is standard under PPTCT, with chlamydia/gonorrhoea added for those at risk. Untreated syphilis in pregnancy causes congenital syphilis, so treatment is essential.
  • Sexual assault: post-assault care includes HIV PEP if indicated, hepatitis B prophylaxis, emergency contraception, presumptive STI treatment, baseline and follow-up testing, and forensic and psychological support. One Stop (Sakhi) Centres in every district provide integrated services, and emergency medical care is free by law.
  • Condom failure: depending on the partner's status, may warrant emergency contraception, HIV PEP, and follow-up STI testing at the right windows.

Testing without anyone else knowing

  • Anonymous testing: NACO ICTC sites can test you under a code, with no name or ID required, the highest level of privacy available.
  • Home self-collection: collecting samples at home and sending them in avoids any clinic visit; results arrive electronically.
  • Telehealth: a video consult plus home collection keeps the whole process at home.
  • Discreet packaging: many online services use plain packaging that does not reveal the contents.
  • Insurance privacy: paying out of pocket keeps testing out of your insurance and employer claims history.
  • Young people: Adolescent Friendly Health Clinics and many NGOs serve under-18s with confidentiality for sexual health matters.
  • LGBTQ+ and criminalised populations: community organisations and NACO Targeted Interventions provide affirming testing with strong confidentiality protections.

When to see a doctor

  • A high-risk HIV exposure in the last 72 hours, condomless sex with an unknown or positive-status partner, a sexual assault, or a needle injury. PEP is time-critical, so go to a NACO ART centre or hospital now.
  • Any genital or pelvic symptoms: unusual vaginal discharge, pain or burning when you urinate, genital sores or ulcers, pain during sex, or new lumps and warts.
  • Lower abdominal or pelvic pain with fever, which can signal pelvic inflammatory disease and needs urgent treatment to protect fertility.
  • Abnormal bleeding, bleeding between periods, or bleeding after sex.
  • A partner has been diagnosed with an STI, even if you feel completely well.
  • A positive or indeterminate result that needs confirmation, treatment, and partner follow-up.

Myths vs facts

Myth: one test rules out everything, forever

A test reflects your status only at the time of testing, and only for the infections it covers. New exposures need new tests, window periods mean timing matters, and no single test covers every infection, which is why panels exist.

Myth: no symptoms means I don't need testing

Most STIs are silent most of the time. Chlamydia is asymptomatic in 70-80 percent of women; Gonorrhea in Women: Symptoms, Testing and Treatment in India, HSV, HPV, and HIV can all be present with no symptoms, yet still transmit to partners and cause serious complications. Routine screening is the standard advice for everyone sexually active.

Myth: testing is expensive and out of reach

NACO ICTC offers free, confidential testing at over 30,000 sites; government hospitals charge only small registration fees; and chain labs offer panels around Rs 2,500-7,000 with home collection and telehealth options.

Myth: a positive result means my life is over

Most bacterial STIs are cured with a short antibiotic course. HIV is now a manageable chronic condition with normal life expectancy on treatment, and U=U means treated HIV is not transmitted sexually. HPV is usually cleared by the immune system, with screening catching any precancerous changes early.

Frequently asked questions

How long after sex should I wait to get tested?

It depends on the infection. Chlamydia and gonorrhoea are reliable from about 2 weeks; syphilis from 3-6 weeks; HIV needs a 4-6 week test plus a 12-week repeat for certainty; hepatitis B and C may take up to 12 weeks or more. For a single worrying exposure, a common approach is a baseline test now and a repeat at the right window.

Can I get tested for free in India?

Yes. NACO ICTC and Suvidha clinics offer free, confidential, often anonymous HIV testing with counselling, and many also offer free syphilis, hepatitis B, and broader STI testing. Government hospitals charge only a small registration fee. Call the NACO helpline 1097 to find your nearest centre.

Do I need a pelvic exam to get tested?

Often not. Many STIs can be tested from a urine sample or a self-collected vaginal swab, both clinically valid for chlamydia, gonorrhoea, and trichomoniasis. HIV, syphilis, and hepatitis use a blood sample. A pelvic exam may be added if you have symptoms or for cervical (Pap) screening.

Will an STI test show up on my insurance or be visible to my family?

Paying out of pocket keeps testing out of your insurance and employer claims history. NACO sites can test you anonymously under a code, and home self-collection plus electronic results means no clinic visit and no paper trail at home.

I had unprotected sex with someone whose status I don't know. What should I do first?

If it was within the last 72 hours and the HIV risk was high, seek HIV PEP urgently at a NACO ART centre or hospital, since it must start within 72 hours. Also consider emergency contraception if pregnancy is a concern, then schedule STI testing at the appropriate windows.

Should both partners get tested before stopping condoms?

It is a sensible, increasingly common practice. Mutual baseline testing before stopping barrier protection supports an informed decision. Remember that How Effective Are Condoms? Failure Rates, Correct Use & STI Protection reduce but do not eliminate the risk of all STIs, so testing complements, rather than replaces, protection.

Sources